Literature DB >> 10153375

Review of the multi-hospital arrangements literature: benefits, disadvantages and lessons for implementation.

B Markham1, J Lomas.   

Abstract

The multi-hospital arrangements literature is reviewed for Canada and the United States. There is a notable lack of evaluations on the outcomes of these arrangements, especially in the Canadian context. For evaluations that do make it to the literature, generalizability of conclusions is difficult because most is based on case studies and relates to "for-profit" U.S. hospitals. We are forced to conclude, however, that there is little definitive evidence that quality of care is improved by multi-hospital arrangements or to support or refute the claims of better human resources deployment. The most striking organizational benefit appears to be that institutions considering merger or other arrangements are forced into explicit considerations of their mission and goals. Many of the potential disadvantages of multi-hospital arrangements may be ameliorated with appropriate strategic planning and attention to detail during negotiation of the arrangement. As new multi-institutional arrangements may cause harm as well as reap benefits, careful evaluation is needed.

Entities:  

Mesh:

Year:  1995        PMID: 10153375     DOI: 10.1016/S0840-4704(10)60916-7

Source DB:  PubMed          Journal:  Healthc Manage Forum        ISSN: 0840-4704


  3 in total

1.  Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines.

Authors:  Astrid Brousselle; Lise Lamothe; Céline Mercier; Michel Perreault
Journal:  Eval Program Plann       Date:  2006-12-26

2.  Integrating services for patients with mental and substance use disorders: What matters?

Authors:  Astrid Brousselle; Lise Lamothe; Chantal Sylvain; Anne Foro; Michel Perreault
Journal:  Health Care Manage Rev       Date:  2010 Jul-Sep

3.  How, when, and why do inter-organisational collaborations in healthcare work? A realist evaluation.

Authors:  Justin Avery Aunger; Ross Millar; Anne Marie Rafferty; Russell Mannion; Joanne Greenhalgh; Deborah Faulks; Hugh McLeod
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.